There was also an investigation of miR‐196b in paediatric AML where miR‐196b expression was highest in FAB M4/5 and FLT3+ITD AML, and specifically correlated with poor remission rates after initial induction and overall poor prognosis [52]. The gene discussed is FLT3; the disease is acute myeloid leukemia.